Core Viewpoint - The company, Jilin Aolaide Optoelectronic Materials Co., Ltd., has received approval from the Shanghai Stock Exchange for its application to issue shares to specific investors through a simplified procedure, pending final registration approval from the China Securities Regulatory Commission (CSRC) [1]. Group 1 - The company’s board of directors guarantees that the announcement contains no false records, misleading statements, or significant omissions, and they bear legal responsibility for the truthfulness, accuracy, and completeness of the content [1]. - The Shanghai Stock Exchange has confirmed that the company's application for a specific object share issuance meets the issuance conditions, listing conditions, and information disclosure requirements [1]. - The final decision and timing regarding the CSRC's approval for the share issuance remain uncertain, and the company will fulfill its information disclosure obligations based on the progress of this matter [1].

Group 1 - The company, Aolide (688378.SH), received a review opinion from the Shanghai Stock Exchange on January 26, 2026, indicating that its application for a private placement of shares meets the issuance conditions, listing conditions, and information disclosure requirements [1] - The private placement of shares is subject to approval from the China Securities Regulatory Commission (CSRC) for registration [1]

吉林奥来德光电材料股份有限公司 关于以简易程序向特定对象发行股票申请 吉林奥来德光电材料股份有限公司向特定对象发行股票申请符合发行条件、 上市条件和信息披露要求。本所将在收到你公司申请文件后提交中国证监会注册。 公司本次以简易程序向特定对象发行股票事项（以下简称"本次发行"）尚 需证监会作出同意注册的决定。本次发行最终能否获得证监会作出同意注册的决 定及其时间尚存在不确定性。公司将根据该事项的进展情况及时履行信息披露义 务，敬请广大投资者注意投资风险。 证券代码：688378 证券简称：奥来德 公告编号：2026-010 获得上海证券交易所审核通过的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 吉林奥来德光电材料股份有限公司（以下简称"公司"）于2026年1月26日收 到上海证券交易所出具的《关于吉林奥来德光电材料股份有限公司向特定对象发 行股票的交易所审核意见》，具体审核意见如下： 特此公告。 吉林奥来德光电材料股份有限公司董事会 2026年1月27日 ...

Core Viewpoint - The company has received approval from the Shanghai Stock Exchange for its application to issue shares to specific investors, indicating compliance with issuance conditions, listing conditions, and information disclosure requirements [1] Group 1 - The company received the review opinion from the Shanghai Stock Exchange on January 26, 2026 [1] - The review opinion states that the company's application for issuing shares to specific investors meets the necessary conditions [1] - The application will be submitted to the China Securities Regulatory Commission for registration after the company submits the required documents [1] Group 2 - The issuance of shares to specific investors will follow a simplified procedure [1] - The approval from the China Securities Regulatory Commission is still required for the registration decision [1]

Group 1: Company Fundraising and Investment - Company plans to use 500 million yuan of raised funds to increase capital in its wholly-owned subsidiaries for the implementation of a DRAM investment project [1] - Zhuhai Hengqin Chip Storage Co., Ltd. will receive 30 million yuan, and Hefei Chip Storage Co., Ltd. and Xi'an Chip Storage Co., Ltd. will receive 50 million yuan and 30 million yuan respectively for the DRAM project [1] Group 2: Profit Forecasts and Turnarounds - Yiling Pharmaceutical expects a net profit of 1.2 billion to 1.3 billion yuan in 2025, recovering from a loss of 725 million yuan in the previous year [2] - Liard anticipates a net profit of 300 million to 380 million yuan in 2025, compared to a loss of 889 million yuan last year, driven by a new strategic cycle focusing on AI [2] - Daming City forecasts a net profit of 140 million to 165 million yuan in 2025, recovering from a loss in the previous year, aided by reduced asset impairment losses [3] - Guanghua Technology expects a net profit of 85 million to 120 million yuan in 2025, recovering from a loss of 205 million yuan last year, due to expansion in specialized chemicals and PCB sectors [3] - Boteng Co. anticipates a net profit of 80 million to 105 million yuan in 2025, recovering from a loss of 288 million yuan, supported by operational efficiency improvements [4] - Shiyida expects a net profit of 31 million to 46 million yuan in 2025, recovering from a loss of 2.34 million yuan last year, driven by business development and cost control [4] - Guochuang High-tech forecasts a net profit of 16 million to 24 million yuan in 2025, recovering from a loss of 49 million yuan, aided by improved receivables management [5][6] Group 3: Share Buybacks - Hengyi Petrochemical plans to repurchase shares with a total fund of no less than 500 million yuan and no more than 1 billion yuan, with a maximum price of 15 yuan per share [7] - Yunyi Electric plans to repurchase shares with a total fund of no less than 100 million yuan and no more than 150 million yuan, with a maximum price of 17 yuan per share [7] - Xidian Pharmaceutical intends to repurchase shares with a total fund of no less than 25 million yuan and no more than 50 million yuan, with a maximum price of 42 yuan per share [7] Group 4: Performance Highlights - Te Yi Pharmaceutical expects a net profit of 70 million to 90 million yuan in 2025, a growth of 241.55% to 339.13% year-on-year [8] - Xingqi Eye Medicine anticipates a net profit of 662 million to 749 million yuan in 2025, a growth of 95.82% to 121.56% year-on-year [8] - Tianhe Co. forecasts a net profit of 41 million to 60 million yuan in 2025, a growth of 84.35% to 169.78% year-on-year [8] - Ruichuang Micro-Nano expects a net profit of approximately 1.1 billion yuan in 2025, a 93% increase year-on-year [9] - Zhongyuan Co. anticipates a net profit of 139 million to 158 million yuan in 2025, a growth of 80% to 105% year-on-year [9] Group 5: Important Corporate Developments - Aolaide has received acceptance for its application to issue securities on the Science and Technology Innovation Board [14] - *ST Songfa's subsidiary signed contracts for the construction of two VLCC super-large oil tankers, expected to positively impact future performance [15] - Chongda Technology's subsidiary signed an investment agreement for a 1 billion yuan IC packaging project in Jiangsu Province [15] - Yinglian Co. signed a strategic agreement with LG Chem to establish a joint laboratory for innovative materials in lithium battery applications [16]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 吉林奥来德光电材料股份有限公司（以下简称"公司"）于2026年1月21日收 到上海证券交易所（以下简称"上交所"）出具的"上证科审（再融资）〔2026〕 7号"《关于受理吉林奥来德光电材料股份有限公司科创板上市公司发行证券申请 的通知》，上交所对公司报送的以简易程序向特定对象发行股票的申请文件进行 了核对，认为申请文件齐备，决定予以受理并依法进行审核。 吉林奥来德光电材料股份有限公司 关于以简易程序向特定对象发行股票申请 获得上海证券交易所受理的公告 证券代码：688378 证券简称：奥来德 公告编号：2026-009 公司本次以简易程序向特定对象发行股票事项（以下简称"本次发行"）尚 需通过上交所审核，并获得中国证券监督管理委员会（以下简称"中国证监会"） 同意注册的批复后方可实施。本次发行最终能否通过上交所审核，并获得中国证 监会同意注册的批复及其时间尚存在不确定性。公司将根据该事项的进展情况及 时履行信息披露义务，敬请广大投资者注意投资风险。 特此公告。 吉林奥来德光电 ...

Group 1 - The core point of the news is that Aolide's stock price has dropped by 5.13% to 32.35 CNY per share, with a trading volume of 223 million CNY and a turnover rate of 2.80%, resulting in a total market capitalization of 8.064 billion CNY [1] - Aolide, established on June 10, 2005, and listed on September 3, 2020, specializes in the research, manufacturing, sales, and after-sales technical services of organic light-emitting materials and evaporation source equipment within the OLED industry chain [1] - The company's main business revenue composition includes organic light-emitting materials at 78.06%, other functional materials at 13.42%, evaporation source equipment at 8.31%, and others at 0.21% [1] Group 2 - According to data from the top ten holdings of funds, Guotou Ruijin Fund has a significant position in Aolide, with its Guotou Ruijin Emerging Industry Mixed Fund (LOF) A (161219) reducing its holdings by 372,700 shares, now holding 666,800 shares, which represents 4.15% of the fund's net value, ranking as the eighth largest holding [2] - The Guotou Ruijin Emerging Industry Mixed Fund (LOF) A (161219) was established on December 13, 2011, with a latest scale of 438 million CNY, achieving a year-to-date return of 8.11%, ranking 2417 out of 8843 in its category, and a one-year return of 41.63%, ranking 2767 out of 8096 [2] - The fund manager, Wang Peng, has been in position for 10 years and 288 days, with the fund's total asset scale at 542 million CNY, achieving the best return of 163.79% and the worst return of 3.45% during his tenure [3]

Market Overview - The optical and optoelectronic sector experienced a decline of 1.58% on January 20, with Infinte leading the drop [1] - The Shanghai Composite Index closed at 4113.65, down 0.01%, while the Shenzhen Component Index closed at 14155.63, down 0.97% [1] Stock Performance - Notable gainers in the optical and optoelectronic sector included: - *ST Yushun (002289): Closed at 29.14, up 5.01% with a trading volume of 27,100 shares and a turnover of 78.21 million yuan - Lehman Optoelectronics (300162): Closed at 9.43, up 3.85% with a trading volume of 894,700 shares and a turnover of 830 million yuan - Baoming Technology (002992): Closed at 48.80, up 2.48% with a trading volume of 43,100 shares and a turnover of 214 million yuan [1] - Major decliners included: - Infinte (300582): Closed at 17.35, down 7.76% with a trading volume of 283,600 shares and a turnover of 501 million yuan - Qianzhao Optoelectronics (300102): Closed at 31.84, down 6.98% with a trading volume of 1,228,500 shares and a turnover of 401.9 million yuan - Geberga (920438): Closed at 37.80, down 6.48% with a trading volume of 54,200 shares and a turnover of 210 million yuan [2] Capital Flow - The optical and optoelectronic sector saw a net outflow of 2.292 billion yuan from institutional investors, while retail investors contributed a net inflow of 1.616 billion yuan [2] - The capital flow for specific stocks showed: - TCL Technology (000100): Net inflow of 1.99 billion yuan from institutional investors, with a net outflow of 305.24 million yuan from retail investors - Lehman Optoelectronics (300162): Net inflow of 55.21 million yuan from institutional investors, with a net inflow of 57.73 million yuan from retail investors [3]

Group 1 - The core point of the article is that Aolide has announced the approval of multiple proposals, including a report on the simplified procedure for issuing stocks to specific targets for the year 2025 [1] Group 2 - Aolide's fifth board of directors held its 25th meeting to review and approve the aforementioned proposals [1] - The report discussed is a revised version of the analysis regarding the stock issuance plan [1]

证券简称：奥来德 证券代码：688378 吉林奥来德光电材料股份有限公司 Jilin OLED Material Tech Co.，Ltd. （吉林省长春市高新开发区硅谷新城生产力大厦 A 座 19 层） 2025 年度以简易程序向特定对象发行 股票方案论证分析报告 （二次修订稿） 二〇二六年一月 吉林奥来德光电材料股份有限公司（以下简称"奥来德"或"公司"）是上 海证券交易所科创板上市公司。为满足公司业务发展需求，增加公司资本实力， 提升盈利能力，根据《中华人民共和国公司法》（以下简称"《公司法》"）《中华 人民共和国证券法》（以下简称"《证券法》"）《上市公司证券发行注册管理办法》 （以下简称"《注册管理办法》"）《上海证券交易所上市公司证券发行上市审核规 则》（以下简称"《上市审核规则》"）等有关法律法规、规范性文件和《公司章程》 的规定，公司编制了以简易程序向特定对象发行股票方案的论证分析报告。 本论证分析报告中如无特别说明，相关用语具有与《吉林奥来德光电材料股 份有限公司 2025 年度以简易程序向特定对象发行股票预案（二次修订稿）》中相 同的含义。 一、本次发行的背景和目的 （一）本次发行的背景 ...